There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s ...

Disease-modifying drugs are now available that slow brain degeneration ... combines these various measures to produce an amyloid pathology risk score. “The primary advantage of LucentAD Complete ...

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

Opens in a new tab or window Depressive symptoms were not consistently associated with Alzheimer's pathology in people without dementia. In people with normal cognition, amyloid and depressive ...

A groundbreaking study reveals how a rare combination of genetics, proteomics, and environmental factors may hold the key to ...

The major focus of our studies has been the identification of the cellular and molecular mechanisms by which specific proteins central to these diseases (e.g., the beta amyloid peptide in AD and ...

The major focus of our studies has been the identification of the cellular and molecular mechanisms by which specific proteins central to these diseases (e.g., the beta amyloid peptide in AD and ...

"In both animal models that model different aspects of this disease, amyloid pathology in one model and tau pathology in another model, xenon has had protective effects in both situations," said Dr.